From: Association between tuberculin skin test result and clinical presentation of tuberculosis disease
Non-cavitary pulmonary disease | Cavitary pulmonary disease | ||||||||
---|---|---|---|---|---|---|---|---|---|
Total | Smear-positive (%) | aOR* | 95% CI* | Total | Smear-positive (%) | aOR | 95% CI | ||
HIV+/US | |||||||||
0–4 mm | 1,073 | 651 (61) | Ref | 183 | 135 (74) | Ref | |||
5–9 mm | 79 | 44 (56) | 0.78 | 0.49, 1.24 | 16 | 14 (88) | 2.66 | 0.58, 12.27 | |
10–14 mm | 603 | 317 (53) | 0.72 | 0.59, 0.88 | 139 | 117 (84) | 1.90 | 1.08, 3.35 | |
≥ 15 mm | 1,182 | 545 (46) | 0.56 | 0.47, 0.66 | 320 | 245 (77) | 1.15 | 0.75, 1.75 | |
Sub-total | 2,937 | 1,557 (53) | 658 | 511 (78) | |||||
HIV+/FB | |||||||||
0–4 mm | 522 | 325 (62) | Ref | 62 | 48 (77) | Ref | |||
5–9 mm | 36 | 24 (67) | 1.20 | 0.59, 2.47 | 7 | 4 (57) | 0.37 | 0.07, 1.86 | |
10–14 mm | 267 | 140 (52) | 0.67 | 0.50, 0.91 | 61 | 37 (61) | 0.45 | 0.20, 1.00 | |
≥ 15 mm | 483 | 217 (45) | 0.50 | 0.39, 0.65 | 130 | 102 (78) | 1.03 | 0.49, 2.16 | |
Sub-total | 1,308 | 706 (54) | 260 | 191 (73) | |||||
HIV-/US | |||||||||
0–4 mm | 2,051 | 1,195 (58) | Ref | 1,430 | 1,232 (86) | Ref | |||
5–9 mm | 285 | 159 (56) | 0.89 | 0.69, 1.14 | 273 | 236 (86) | 0.99 | 0.68, 1.44 | |
10–14 mm | 2,759 | 1,504 (55) | 0.84 | 0.74, 0.94 | 2,137 | 1,795 (84) | 0.78 | 0.64, 0.95 | |
≥ 15 mm | 7,576 | 3,745 (49) | 0.69 | 0.62, 0.76 | 5,960 | 5,027 (84) | 0.80 | 0.68, 0.95 | |
Sub-total | 12,671 | 6,603 (52) | 9,800 | 8,290 (85) | |||||
HIV-/FB | |||||||||
0–4 mm | 831 | 468 (56) | Ref | 600 | 482 (80) | Ref | |||
5–9 mm | 314 | 159 (51) | 0.78 | 0.60, 1.02 | 180 | 150 (83) | 1.23 | 0.79, 1.91 | |
10–14 mm | 2,702 | 1,338 (50) | 0.74 | 0.63, 0.87 | 1,790 | 1,466 (82) | 1.10 | 0.87, 1.39 | |
≥ 15 mm | 7,992 | 3,626 (45) | 0.62 | 0.54, 0.72 | 4,637 | 3,754 (81) | 1.03 | 0.83, 1.28 | |
Sub-total | 11,839 | 5,591 (47) | 7,207 | 5,852 (81) | |||||
Total | 28,755 | 14,457 (50) | 19,925 | 14,844 (83) |